Medical Condition News

RSS

Predictors of an Asian diabetes epidemic: A study

Experts believe diabetes will be the leading disease in Asia mainly because of the rise in consumption of junk and high calorie foods in this region of the world.

13 Jul 2010

Fredericksburg Oncology invites participants for new metastatic melanoma clinical trial

Fredericksburg Oncology is now accepting patients for a new clinical trial supported by the National Cancer Institute (NCI) to evaluate treatment for metastatic (advanced stage) melanoma. The current trial, designed at the Mayo Clinic, combines chemotherapy with targeted molecular agents in an effort to improve control of this difficult disease, reports Dr. Frederick C. Tucker, Jr., who heads this practice.

13 Jul 2010

Role of enzyme GSTP1-1 in progression of cancer, other diseases associated with increased cell proliferation

Telik, Inc. today announced the publication of a review in the journal, Cell Death and Differentiation: Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death; http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201080a.html. This review describes recent advances in the understanding of the important role that the enzyme GSTP1-1 plays in the progression of cancer and other diseases associated with increased cell proliferation.

13 Jul 2010

Custom-made bone replacements for facial reconstruction soon

Facial reconstruction patients may soon have the option of custom-made bone replacements optimized for both form and function, thanks to researchers at the University of Illinois and the Ohio State University Medical Center.

13 Jul 2010

Experts gather evidence to support policy making on marketing of foods to children

The last six years have seen significant progress in efforts to curb the marketing of unhealthy food to children, with an increasing number of governments taking on the issue, but considerable challenges remain, a leading expert on the topic said today (Tuesday).

13 Jul 2010

SCENESSE reduces, prevents phototoxic reactions experienced by EPP patients in Phase III trial

A new Australian drug has been shown to assist in protecting patients with a rare genetic disorder that makes their skin toxic to light and UV, and previously forced them to live in the shadows.

13 Jul 2010

New research shows Weight Watchers helps people lose weight effectively

New research unveiled at the International Congress on Obesity is further evidence of how Weight Watchers helps people around the world lose weight effectively, and has the potential to collaborate further with public health care providers worldwide to help reverse the obesity epidemic.

13 Jul 2010

Combined behavioral interventions most effective way to reduce heart disease risk

Combining counseling, extended follow-up with a healthcare provider and self-monitoring of diet and exercise is the most effective way to help patients embrace lifestyle changes that can lower their risk for heart and blood vessel (cardiovascular) diseases, according to a scientific statement published in Circulation: Journal of the American Heart Association.

13 Jul 2010

Researchers use topological optimization to design facial bone replacements

Scientists are using the engineering technology behind the creation of high-performance aircraft components to design 3-D models for the replacement of delicate and complex facial bones lost to cancer surgery or trauma.

13 Jul 2010

Community-based interventions for childhood obesity differ depending on age group, expert says

Community-based interventions designed to prevent obesity in children seem to work best in those under the age of five, while there is evidence of some success in primary school children, but very mixed effects in adolescents, a leading expert in the field said today (Tuesday).

13 Jul 2010

Protalix BioTherapeutics' taliglucerase alfa for Gaucher disease granted French ATU

Protalix BioTherapeutics, Inc. announced today that the French regulatory authority has granted an Autorisation Temporaire d'Utilisation (ATU), or Temporary Authorization for Use, for taliglucerase alfa for the treatment of Gaucher disease. An ATU is the regulatory mechanism used by the French Health Products and Safety Agency to make non-approved drugs available to patients in France when a genuine public health need exists.

13 Jul 2010

BioImage Study published in American Heart Journal

BG Medicine, Inc., a U.S.-based biomarker discovery and in vitro diagnostics company, announced today the publication of The BioImage Study trial design and key objectives in the American Heart Journal. The American Heart Journal is a peer- reviewed journal that publishes original research and review articles on clinical research studies in the field of cardiology.

13 Jul 2010

MAP Pharmaceuticals reports results from LEVADEX PK and safety clinical trial in smokers, non-smokers

MAP Pharmaceuticals, Inc. today announced results from a clinical trial comparing the pharmacokinetics (PK) and safety of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. The trial was designed to measure whether systemic absorption and exposure in smokers is greater than in non-smokers. In the trial, the systemic absorption of LEVADEX was not higher and systemic exposure to DHE was not greater in smokers than in non-smokers.

13 Jul 2010

EntreMed announces publication of preclinical data for ENMD-2076

EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.

13 Jul 2010

Deaf, hard of hearing individuals to be provided equal access at N.Y. nursing and rehabilitation facility

Under an agreement announced today by the Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services, individuals who are deaf or hard of hearing will be provided equal access to a nursing and rehabilitation facility in New York State and will be provided interpretation services when necessary for effective communication.

13 Jul 2010

Researchers discover single genetic mutation that accounts for disease

By inspecting the sequence of all 3 billion "letters" that make up the genome of a single person affected with a rare, inherited disorder, a Johns Hopkins and Duke University team ferreted out the single genetic mutation that accounts for the disease.

13 Jul 2010

Speaker Pelosi praises Obama's announcement to help veterans with PTSD get easier access to treatment

Speaker Nancy Pelosi released the following statement today praising President Obama's announcement that the Department of Veterans Affairs will start making it easier for veterans with Post Traumatic Stress Disorder to receive critical health and disability benefits and treatment:

13 Jul 2010

Line of moisture absorber products available to eliminate dampness that enables mold to grow

The stifling humidity accompanying this summer's extreme temperatures increases the chance that homeowners will experience significant indoor humidity and moisture that may lead to musty odors, allergens, and mold and mildew that lead to or aggravate allergies, asthma and other health concerns and can even lead to structural damage.

13 Jul 2010

Researchers watch armed tumor-seeking immune system cells attack dangerous melanomas in real time

Researchers at UCLA's Jonsson Comprehensive Cancer Center created a large, well armed battalion of tumor-seeking immune system cells and watched, in real time using Positron Emission Tomography (PET), as the special forces traveled throughout the body to locate and attack dangerous melanomas.

13 Jul 2010

Memoir traces lifelong, undetected bipolar disorder

When Jerry Jewler turned 60, he celebrated his "coming of age" with a splashy party -- and a glorious high. The next day, he awoke to a hell he had never known: sad and depressed, unable to make even idle chatter with his houseguests, and angry at the world.

13 Jul 2010

Medical Condition News

Predictors of an Asian diabetes epidemic: A study

Fredericksburg Oncology invites participants for new metastatic melanoma clinical trial

Role of enzyme GSTP1-1 in progression of cancer, other diseases associated with increased cell proliferation

Custom-made bone replacements for facial reconstruction soon

Experts gather evidence to support policy making on marketing of foods to children

SCENESSE reduces, prevents phototoxic reactions experienced by EPP patients in Phase III trial

New research shows Weight Watchers helps people lose weight effectively

Combined behavioral interventions most effective way to reduce heart disease risk

Researchers use topological optimization to design facial bone replacements

Community-based interventions for childhood obesity differ depending on age group, expert says

Protalix BioTherapeutics' taliglucerase alfa for Gaucher disease granted French ATU

BioImage Study published in American Heart Journal

MAP Pharmaceuticals reports results from LEVADEX PK and safety clinical trial in smokers, non-smokers

EntreMed announces publication of preclinical data for ENMD-2076

Deaf, hard of hearing individuals to be provided equal access at N.Y. nursing and rehabilitation facility

Researchers discover single genetic mutation that accounts for disease

Speaker Pelosi praises Obama's announcement to help veterans with PTSD get easier access to treatment

Line of moisture absorber products available to eliminate dampness that enables mold to grow

Researchers watch armed tumor-seeking immune system cells attack dangerous melanomas in real time

Memoir traces lifelong, undetected bipolar disorder

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News